Communiqués Exicure, Inc.

Actions

XCUR

US30205M2008

Temps Différé Nasdaq Autres places de cotation 18:38:38 03/07/2024			Varia. 5j.	Varia. 1 janv.
0,3152 ^USD	+1,61%		+0,32%	-45,68%

17/06	Exicure, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
06/06	Exicure, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Exicure, Inc. Reports First Quarter 2024 Financial Results	17/06	BU
Exicure, Inc. Reports Full Year 2023 Financial Results	06/06	BU
Exicure, Inc. Received Nasdaq Notice of a Delisting Determination	23/05	BU
Exicure, Inc. Reports Third Quarter 2023 Financial Results	16/05	BU
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K	22/04	BU
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	05/02	BU
Exicure : Non-Reliance on Previously Issued Financial Report - Form 8-K	01/12	PU
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q	28/11	BU
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors	23/08/23	BU
Exicure : Announces Appointment of New CEO and CFO and Changes to Board of Directors - Form 8-K	23/08/23	PU
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update	14/08/23	AQ
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update	11/08/23	BU
Exicure Reports First Quarter 2023 Financial Results and Provides Corporate Update	17/07/23	AQ
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update	14/07/23	BU
EXICURE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	14/06/23	AQ
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives	29/05/23	AQ
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives	26/05/23	BU
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q	19/05/23	BU
EXICURE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	18/05/23	AQ
EXICURE, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	11/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Exicure, Inc.

Actions

XCUR

US30205M2008

Communiqués

Filtres